EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 327 filers reported holding EXELIXIS INC in Q4 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,351,544 | +8.0% | 146,605 | +5.5% | 0.05% | +4.4% |
Q3 2022 | $2,178,000 | -26.2% | 138,934 | -2.0% | 0.04% | -19.6% |
Q2 2022 | $2,951,000 | -12.1% | 141,741 | -4.2% | 0.06% | +7.7% |
Q1 2022 | $3,356,000 | +35.1% | 148,016 | +8.9% | 0.05% | +44.4% |
Q4 2021 | $2,485,000 | +17.5% | 135,920 | +17.1% | 0.04% | +9.1% |
Q3 2021 | $2,114,000 | 0.0% | 116,048 | 0.0% | 0.03% | +17.9% |
Q2 2021 | $2,114,000 | -7.6% | 116,048 | +14.6% | 0.03% | -17.6% |
Q1 2021 | $2,287,000 | -18.6% | 101,237 | -27.7% | 0.03% | -20.9% |
Q4 2020 | $2,809,000 | +34.1% | 139,944 | +63.4% | 0.04% | +19.4% |
Q3 2020 | $2,094,000 | – | 85,637 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 11,275,871 | $254,722,000 | 71.55% |
GREAT POINT PARTNERS LLC | 1,201,100 | $27,133,000 | 5.61% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 886,534 | $20,027,000 | 5.30% |
Sargent Investment Group, LLC | 498,350 | $11,258,000 | 2.96% |
CAPITAL MANAGEMENT CORP /VA | 311,660 | $7,040,000 | 1.57% |
EULAV Asset Management | 2,460,000 | $55,571,000 | 1.49% |
CM Management, LLC | 80,000 | $1,807,000 | 1.34% |
Integral Health Asset Management, LLC | 200,000 | $4,518,000 | 1.29% |
FARALLON CAPITAL MANAGEMENT LLC | 10,750,000 | $242,843,000 | 1.21% |
Sofinnova Investments, Inc. | 839,181 | $18,957,000 | 1.14% |